Exposure to Glyphosate Linked to Non-Hodgkin Lymphoma and Multiple Myeloma
In this study, Chinese scientists working at Lerner Research Institute at the Cleveland Clinic in Cleveland, Ohio, found that mice exposed to glyphosate exhibit multiple blood and plasma abnormalities and damage to bodily organs. They also discovered that exposure to glyphosate induced in the mice a biochemical mechanism that is known to play a role in the development of two types of blood cancers: multiple myeloma (MM) and B-cell lymphoma, which accounts for approximately 90% of non-Hodgkin lymphoma (NHL).
It is one thing to find a significant association between a toxic chemical and a disease, such as the link found in this study between glyphosate exposure and kidney and liver damage. It takes additional evidence to move from there to a conclusion that there is a causative relationship at work—to say the toxin is causing the disease.
To establish causation, scientists study the effects of the toxin in animals that have biological similarities to humans. They look for changes at the cellular and molecular level that might reveal the biological pathways that lead from toxin exposure to the appearance of the disease.
“We uncover a B cell-specific mutational mechanism for glyphosate exposure that increases MM and NHL risk, providing a molecular basis for human epidemiological findings.” – Lei Wang et al. See study details below.
Glyphosate Exposure Induces Key Mechanism in Cancer Pathway
Unlike prior mouse glyphosate carcinogenicity studies, the Wang authors used a mouse strain that is “widely regarded as the best animal model for MM.”
Their study found that exposure to glyphosate activates a key mechanism known to play a role in the development of non-Hodgkin lymphoma and multiple myeloma. Activation-induced cytidine deaminase (also known as AID) is an enzyme that creates mutations in DNA. It does this by actually altering the base pairs that form the “stair steps” in the DNA double-helix ladder. A guanine-cytosine pairing might be converted to an adenine-thymine pair. AID can result in multiple DNA mutations, some occurring when DNA repair mechanisms are engaged.
AID can produce beneficial results for the immune system, but it can also lead to B-cell lymphoma. Wang et al found that glyphosate exposure caused an increase in the production of AID in the spleen and bone marrow in the study mice. AID, they write, “is a B cell-specific genome mutator and a key pathogenic player in both MM and B cell lymphoma.”
“Our data disclose, for the first time, that glyphosate elicits a B cell-specific mutational mechanism of action in promoting carcinogenesis, as well as offering experimental evidence to support the epidemiologic finding regarding its tissue specificity in carcinogenesis (i.e., only increasing the risk for MM and NHL)." – Lei Wang et al. See study details below.
The authors of this study make a very important observation related to causality. While previous studies have revealed several mechanisms by which glyphosate can induce DNA damage, they “failed to explain why glyphosate is only positively associated with MM and NHL.” The discovery of a mechanism that is specifically tied to the two cancers most associated with glyphosate offers strong evidence that glyphosate is causing these diseases.
It should be noted that both of the plaintiffs in the most recent Roundup trial, Alva and Alberta Pilliod, got B-cell lymphoma after using Roundup.
Blood Abnormalities and Organ Damage
The researchers also found that exposure to glyphosate damaged several organs and produced blood abnormalities in the mice that mirror conditions that precede or coincide with multiple myeloma and NHL.
Exposure to glyphosate triggered “multiple organ dysfunction”
in the mice, including:
- Bone lesions
- Liver damage
- Severe lung damage
- Kidney damage
- Mice exposed to glyphosate in their drinking water developed “progressive plasma cell neoplasms.” (A neoplasm is an abnormal tissue growth characteristic of cancer. Plasma cells are derived from white blood cells called B cells and help the body fight foreign substances.) The exposed mice exhibited “a marked increase” in plasma cells in the spleen and bone marrow. An increase in plasma cells is characteristic of a condition that nearly always precedes multiple myeloma known as monoclonal gammopathy of undetermined significance, or MGUS. MGUS itself usually harmless, but can progress to more serious disease, including blood cancers.
- Exposure to glyphosate also produced increased levels of immunoglobin G (IgG), the most common type of antibody found in the blood and body fluids. According to the authors, the steadily increasing IgG levels suggest that exposure to glyphosate induces in mice a condition that is “equivalent to human MGUS.” Increases in IgG are also frequently found in patients with Hodgkin and non-Hodgkin lymphoma.
The full study is available online.
Glyphosate induces benign monoclonal gammopathy and promotes multiple myeloma progression in mice
Lei Wang1,2, Qipan Deng1, Hui Hu1,3, Ming Liu1,4, Zhaojian Gong1,5, Shanshan Zhang1,6, Zijun Y. Xu-Monette7, Zhongxin Lu3, Ken H. Young7, Xiaodong Ma1,8,9, and Yong Li1
- Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
- School of Life Sciences, Institute of Modern Aquaculture Science and Engineering, Guangdong Provincial Key Laboratory for Healthy and Safe Aquaculture, South China Normal University, Guangzhou 510631, China.
- Department of Medical Laboratory, Central Hospital of Wuhan, Wuhan, China.
- State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
- Department of Stomatology, the Second Xiangya Hospital, Central South University, Changsha, China.
- Department of Stomatology, Xiangya Hospital, Central South University, Changsha, China.
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou 510631, China.
- The Research Center of Basic Integrative Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Journal of Hematology & Oncology (2019),12(1):70
YL is supported in part by NIH R01 grants (CA138688 and CA177810); LW is supported by National Natural Science Foundation of China (NO. 31500326) and Natural Science Foundation of Guangdong Province of China (NO. 2017A030313194).
Hardeman v. Monsanto Co. $80 Million Verdict
Baum Hedlund Aristei & Goldman attorneys served on the trial team in the case of Hardeman v. Monsanto Company, which resulted in an $80 million jury verdict for the plaintiff, Edwin Hardeman.
Toxic Torts $289.2 Million Verdict
On Aug. 10, 2018, a San Francisco jury ordered Monsanto to pay $39.25 million in compensatory damages and $250 million in punitive damages to Mr. Johnson, a former groundskeeper who alleged exposure to Monsanto’s herbicides caused him to develop terminal non-Hodgkin lymphoma.
Toxic Torts $2.0 Billion Verdict
In May of 2019, the jury in the case of Pilliod et al. v, Monsanto Company ordered the agrochemical giant to pay $2.055 billion in damages to the plaintiffs, Alva and Alberta Pilliod, a Bay Area couple in their 70s.
A ranking in The U.S. News – Best Lawyers® “Best Law Firms” is widely regarded by both client and legal professionals as a significant honor. It is considered the most reliable, unbiased source of legal referrals anywhere.
Wisner Baum is proud to be a sponsor of The Truck Safety Coalition, a a group of caring individuals dedicated to reducing the number of deaths and injuries caused by truck-related crashes. Our support enables them to help families and save lives.
Law360 recognizes law firms that have a strong regional presence, working on important matters within their home state. “[Wisner Baum] possesses a David v. Goliath-sized slingshot while seeking justice for everyday citizens it believes were harmed or killed through corporate wrongdoing.”
NLJ and American Lawyer Media honor law firms and attorneys as Elite Trial Lawyers for their cutting-edge legal work on behalf of plaintiffs in practice areas ranging from mass torts to securities litigation.
Best Lawyers is the oldest and most respected peer-review publication in the legal profession. A listing in Best Lawyers is widely regarded by both clients and legal professionals as a significant honor, conferred on a lawyer by his or her peers.
Less than one-half of one percent of firms across the nation have achieved this ranking. A firm must have a high percentage of lawyers who have achieved the prestigious AV® Preeminent rating by Martindale-Hubbell®.
The National Law Journal inducted Wisner Baum into the Verdicts Hall of Fame for obtaining the $2 billion landmark verdict in the Roundup cancer case of Pilliod et al. v. Monsanto. The verdict was #1 in California and #2 in the U.S. in 2019 and is #9 in American history.
Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high-degree of peer recognition and professional achievement.
The National Trial Lawyers Top 100 recognized the law firms of Wisner Baum, the Miller Firm and Audet & Partners with the 2019 Trial Team of the Year award (in the Mass Torts category) for their work in the groundbreaking case of Dewayne “Lee” Johnson v. Monsanto Company.
An AV® rating reflects an attorney who has reached the heights of professional excellence. The rating signifies the highest legal ability, and very high adherence to professional standards of conduct, ethics, reliability, and diligence.
Wisner Baum is proud to have all of its lawyers listed in Avvo, a legal directory connecting people in need of legal services with lawyers and connecting lawyers to lawyers. Eight of our attorneys have earned a 10.0 perfect rating with Avvo.
CA and USA
TopVerdict.com ranks our $2 billion verdict in Pilliod et al. v. Monsanto as the biggest verdict in California and the second largest verdict in the U.S. in 2019. It is the ninth largest verdict in U.S. history.
Published annually, the Lawdragon 500 Leading Plaintiff Consumer Lawyers list recognizes the “best of the best” in this area of the law through nominations, research, and review by a board of their peers.
In 2020, Law360 honored the law firms ”behind the litigation wins and major deals that resonated throughout the legal industry.” It recognized our success in several landmark cases.
In 2018, our $289 million Johnson v. Monsanto verdict was the largest personal injury verdict in California. TopVerdict.com also ranked it #2 among all verdicts in California and #10 in the nation.
The Bar Register is the definitive guide to the most distinguished law firms in America. It includes only those select law practices that have earned the highest rating in the Martindale-Hubbell Law Directory and have been designated by their colleagues as preeminent in their field.
Firm ReviewsWhat Our Clients Are Saying
I Can’t Imagine a Better Law Firm- Best Law Firms Survey
They Are About Changing the Systems...- Kim Witczak
Top Legal Minds in the Country- From Best Lawyers® Best Law Firms
Diligent & Professional Representation- W.T.
Our Best Interest Was Always Number One on Your List- G.C. & C.C